Intervention not reported
Systolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Diastolic blood pressure · adults with primary hypertension
1 finding from 1 review
Intervention not reported
Withdrawal due to adverse effects · adults with primary hypertension
1 finding from 1 review
Long‐term mortality · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Mortality before hospital discharge · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
It is very uncertain whether inhaled nitric oxide changes mortality prior to discharge1 compared with placebo or conventional therapy (very low certainty).
1 finding from 1 review
Difference in MPAP change score (SE) ‐ Conventional Management4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Difference in MPAP change score (SE) ‐ Placebo4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
no estimate extracted
1 study · 2 participants
Very low
Difference in MAP change score (SE) ‐ Conventional Mangement4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
Difference in MAP change score (SE) ‐ Placebo4 · all infants and children with congenital heart disease having postoperative management of pulmonary hypertension
1 finding from 1 review
no estimate extracted
1 study · 2 participants
Very low
Intervention not reported
Decrease in systolic blood pressure · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in diastolic blood pressure · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in heart rate · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Decrease in pulse pressure · Adults with primary hypertension
1 finding from 1 review
Intervention not reported
Withdrawal due to adverse effect · Adults with primary hypertension
1 finding from 1 review
SBP (mmHg) · adults with primary hypertension
1 finding from 1 review
Diastolic blood pressure · adults with primary hypertension
1 finding from 1 review
Heart rate · adults with primary hypertension
1 finding from 1 review
Pulse pressure · adults with primary hypertension
1 finding from 1 review
Withdrawals due to adverse events · adults with primary hypertension
1 finding from 1 review
Intervention not reported
High‐ versus low‐dose · children (from 1 to 18 years of age) with hypertension from primary or secondary causes
1 finding from 1 review